Translational researchers in complement therapeutics and microfluidics often require experimental systems that provide more than a single endpoint. Challenges such as assay variability, limited functional readouts, inconsistent droplet formation, and fragmented workflows can complicate data interpretation and slow research progress. Although these fields involve different experimental challenges, both benefit from carefully selected research tools, well-defined experimental conditions, and reliable measurements. Creative Biolabs is highlighting a selection of research products and services designed to support functional evaluation and experimental control across complement biology and droplet microfluidics.
Complement-targeted drug research often requires an understanding of whether a candidate influences pathway activity at the functional level. Binding data alone may provide limited information about downstream biological effects, making complementary functional assays useful during inhibitor characterization. To support classical pathway studies, Creative Biolabs offers its CH50 functional test kit, a hemolysis-based assay developed for measuring the functional activity of the classical complement pathway through antibody-sensitized red blood cell lysis. The kit is designed for serum or plasma samples from multiple species, including humans, mice, and rats, and can be used in complement function studies as well as research involving complement inhibitors or activators.
For programs requiring additional functional characterization, the company's hemolysis inhibition profiling service uses hemolytic readouts to assess changes in complement-mediated red blood cell lysis following inhibitor treatment. By examining concentration-dependent inhibition responses, the service can support inhibitor potency assessment, comparative activity profiling, and mechanism-of-action investigations. Depending on the research objectives, classical or alternative pathway assays may be incorporated to address pathway-specific questions. By incorporating functional readouts alongside other analytical methods, researchers may gain a broader view of how candidate molecules interact with the complement cascade, helping distinguish target-binding activity from downstream functional inhibition under defined assay conditions.
Researchers using droplet microfluidics face a different but related challenge: generating droplets with suitable consistency for encapsulation, screening, and compartmentalized assay workflows. Creative Biolabs' flow focusing droplet generation chip uses a flow-focusing configuration in which interactions between a continuous phase and a dispersed phase promote droplet formation within microchannels. The PDMS-based chip is designed for water-in-oil and oil-in-water droplet generation and can also be applied to research involving single-cell encapsulation. Such microfluidic systems may help researchers establish more controlled experimental conditions while adapting droplet generation parameters to specific study requirements, with potential applications including sample compartmentalization, cell encapsulation, and the development of droplet-based screening workflows.
Although functional complement testing and droplet microfluidics address distinct experimental requirements, both reflect the importance of selecting appropriate research tools and measurable endpoints. By providing functional complement assay solutions alongside microfluidic research tools, Creative Biolabs aims to support researchers working to refine experimental workflows, broaden functional characterization, and select research formats suited to different biological questions. All referenced products and services are intended for research use only and are not for diagnostic or therapeutic use in humans.
